Oncomedics created the Oncogramme®: it is an in vitro medical device that allows identifying the most appropriate drug/drug combination to target the patient’s cancer cells. The Oncogramme® requires no biomarker or genomic profiling. It is a functional assay, that may offer a personalised treatment to all patients by transforming chemotherapy into a targeted therapy. We offer licensing of our technology to partner lab, and we sell them kit including all reagent to performed the Oncogramme.
1 avenue d’ester 87000 Limoges FRANCE
Targeted indications : Breast cancer, Lung cancer, Colorectal cancer, Brain cancer, Gynecological cancers